Affordable Access

Access to the full text

Application of Artificial Intelligence in COVID-19 Diagnosis and Therapeutics

Authors
  • asada;, ken
Publication Date
Sep 03, 2021
Identifiers
DOI: 10.3390/jpm11090886
OAI: oai:mdpi.com:/2075-4426/11/9/886/
Source
MDPI
Keywords
Language
English
License
Green
External links

Abstract

The coronavirus disease 2019 (COVID-19) pandemic began at the end of December 2019, giving rise to a high rate of infections and causing COVID-19-associated deaths worldwide. It was first reported in Wuhan, China, and since then, not only global leaders, organizations, and pharmaceutical/biotech companies, but also researchers, have directed their efforts toward overcoming this threat. The use of artificial intelligence (AI) has recently surged internationally and has been applied to diverse aspects of many problems. The benefits of using AI are now widely accepted, and many studies have shown great success in medical research on tasks, such as the classification, detection, and prediction of disease, or even patient outcome. In fact, AI technology has been actively employed in various ways in COVID-19 research, and several clinical applications of AI-equipped medical devices for the diagnosis of COVID-19 have already been reported. Hence, in this review, we summarize the latest studies that focus on medical imaging analysis, drug discovery, and therapeutics such as vaccine development and public health decision-making using AI. This survey clarifies the advantages of using AI in the fight against COVID-19 and provides future directions for tackling the COVID-19 pandemic using AI techniques.

Report this publication

Statistics

Seen <100 times